Add to ORKGBACKGROUND: The safety and efficacy of the slow-release, polymer-based, paclitaxel-eluting stent after implantation in a broad cross section of de novo coronary lesions at 1 year are unknown. METHODS AND RESULTS: In the TAXUS-IV trial, 1314 patients with single de novo coronary lesions 10 to 28 mm in length, with reference-vessel diameter 2.5 to 3.75 mm, coverable by a single study stent, were prospectively randomized to the slow-release, polymer-based, paclitaxel-eluting TAXUS stent or an identical-appearing bare-metal EXPRESS stent. By actuarial analysis, the TAXUS stent compared with the bare-metal stent reduced the 12-month rates of target-lesion revascularization by 73% (4.4% versus 15.1%, P CONCLUSIONS: The relative efficacy reported ...
ObjectivesWe sought to investigate the outcomes of paclitaxel-eluting stent implantation in patients...
ObjectivesThis study sought to demonstrate the noninferiority of polymer-free amphilimus-eluting ste...
ObjectivesWe sought to determine the safety and efficacy of polymer-regulated site-specific delivery...
BACKGROUND: The TAXUS II trial was designed to evaluate the safety and efficacy of the commercialize...
BACKGROUND: The TAXUS II trial was designed to evaluate the safety and efficacy of the commercialize...
AIMS: Drug-eluting stents (DESs) have shown to be effective in reducing in-stent restenosis, althoug...
Background—The TAXUS II trial was designed to evaluate the safety and efficacy of the commercialized...
AIMS: To assess the long-term safety and efficacy of the paclitaxel-eluting TAXUS moderate-release (...
AIMS: To assess the long-term safety and efficacy of the paclitaxel-eluting TAXUS moderate-release (...
Background—Early clinical studies demonstrated the feasibility of local paclitaxel delivery in reduc...
BACKGROUND: The first clinical study of paclitaxel-eluting stent for de novo lesions showed promisin...
BACKGROUND: Early clinical studies demonstrated the feasibility of local paclitaxel delivery in redu...
BACKGROUND: Intracoronary polymer-based stent delivery of paclitaxel has been shown to be effective ...
ObjectivesThe pivotal TAXUS IV (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Pa...
ObjectivesThe goal of this research was to assess non-inferiority of the next-generation TAXUS Liber...
ObjectivesWe sought to investigate the outcomes of paclitaxel-eluting stent implantation in patients...
ObjectivesThis study sought to demonstrate the noninferiority of polymer-free amphilimus-eluting ste...
ObjectivesWe sought to determine the safety and efficacy of polymer-regulated site-specific delivery...
BACKGROUND: The TAXUS II trial was designed to evaluate the safety and efficacy of the commercialize...
BACKGROUND: The TAXUS II trial was designed to evaluate the safety and efficacy of the commercialize...
AIMS: Drug-eluting stents (DESs) have shown to be effective in reducing in-stent restenosis, althoug...
Background—The TAXUS II trial was designed to evaluate the safety and efficacy of the commercialized...
AIMS: To assess the long-term safety and efficacy of the paclitaxel-eluting TAXUS moderate-release (...
AIMS: To assess the long-term safety and efficacy of the paclitaxel-eluting TAXUS moderate-release (...
Background—Early clinical studies demonstrated the feasibility of local paclitaxel delivery in reduc...
BACKGROUND: The first clinical study of paclitaxel-eluting stent for de novo lesions showed promisin...
BACKGROUND: Early clinical studies demonstrated the feasibility of local paclitaxel delivery in redu...
BACKGROUND: Intracoronary polymer-based stent delivery of paclitaxel has been shown to be effective ...
ObjectivesThe pivotal TAXUS IV (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Pa...
ObjectivesThe goal of this research was to assess non-inferiority of the next-generation TAXUS Liber...
ObjectivesWe sought to investigate the outcomes of paclitaxel-eluting stent implantation in patients...
ObjectivesThis study sought to demonstrate the noninferiority of polymer-free amphilimus-eluting ste...
ObjectivesWe sought to determine the safety and efficacy of polymer-regulated site-specific delivery...